(Q35860128)

English

Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection

scientific article published on 18 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection (English)

1 reference

Europe PubMed Central

10 August 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

Lluís Ballell

11

0 references

object named as

Neeraj Dhar

2

0 references

Jean-Emmanuel Hugonnet

object named as

Jean-Emmanuel Hugonnet

7

0 references

object named as

Michel Arthur

8

0 references

Iñigo Angulo-Barturen

9

object named as

Iñigo Angulo-Barturen

1 reference

Europe PubMed Central

10 August 2017

author name string

Joaquín Rullas

1

1 reference

Europe PubMed Central

10 August 2017

John D McKinney

3

1 reference

Europe PubMed Central

10 August 2017

Adolfo García-Pérez

4

1 reference

Europe PubMed Central

10 August 2017

Joël Lelievre

5

1 reference

Europe PubMed Central

10 August 2017

Andreas H Diacon

6

1 reference

Europe PubMed Central

10 August 2017

David Barros-Aguirre

10

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

18 May 2015

1 reference

Europe PubMed Central

10 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

10 August 2017

59

1 reference

Europe PubMed Central

10 August 2017

8

1 reference

Europe PubMed Central

10 August 2017

4997-4999

1 reference

Europe PubMed Central

10 August 2017

Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

In vitro susceptibility of Mycobacterium tuberculosis isolates to an oral carbapenem alone or in combination with β-lactamase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Activity of carbapenems combined with clavulanate against murine tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Imipenem for treatment of tuberculosis in mice and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Activity of amoxicillin/clavulanate in patients with tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

11 July 2018

Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

24 September 2018

Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505286

24 September 2018

Oldie but goodie: Repurposing penicillin for tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25987618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.01063-15

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35860128&oldid=2139762893"